May 8th 2024
Discover the findings from a recent study highlighting the need to enhance vaccination rates among pregnant individuals living with HIV, shedding light on key factors influencing vaccine receipt.
23rd Annual International Congress on the Future of Breast Cancer® East
July 19-20, 2024
Register Now!
15th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 11, 2024
View More
Community Practice Connections™: 14th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies
View More
4th Annual International Congress on the Future of Women’s Health™
View More
Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments
View More
Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions
View More
Examining spontaneous abortion risk in infertile patients: The crucial role of pregnancy ultrasound
November 13th 2023Uncover the nuanced relationship between bleeding, ultrasound findings, and spontaneous abortion risk in individuals undergoing embryo transfer for a singleton intrauterine pregnancy.
Read More
Maternal depressive symptoms before conception revealed in new study
November 10th 2023Explore the findings from a JAMA Network Open study, uncovering the stability of maternal depressive symptoms from pregnancy through 2 years postdelivery, highlighting a need for updated public health policies and timely interventions.
Read More
Treating heavy menstrual bleeding: Levonorgestrel system vs combined oral contraceptives
November 8th 2023In a recent study, patients who were treated for heavy menstrual bleeding with the levonorgestrel intrauterine system had similar changes in bleeding-related quality of life as those using combined oral contraceptives for treatment.
Read More
Glucose monitoring cutoff for GDM associated with adverse outcomes
October 11th 2023In a recent study, adverse neonatal outcomes were more common among individuals with a time above the target range of 10% or more when receiving continuous glucose monitoring for gestational diabetes mellitus screening.
Read More
CDC recommends Pfizer’s maternal RSV vaccine to protect newborns
September 26th 2023Ahead of the first fall and winter virus seasons in which vaccines are available for COVID-19, influenza, and respiratory syncytial virus (RSV), the Centers for Disease Control and Prevention is recommending Pfizer’s maternal vaccine to protect newborns from severe RSV illness.
Read More